SML0452

AZ513

≥98% (HPLC)

• Synonim(y): 2,3-Dichloro-N-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide
• Wzór empiryczny (zapis Hilla): C₁₄H₉Cl₂N₃O
• Numer CAS: 1335231-15-6
• Masa cząsteczkowa: 306.15
• NACRES: NA.77
• PubChem Substance ID: 329824731
• UNSPSC Code: 12352200
• MDL number: MFCD22666398
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 15 mg/mL (clear solution)
• storage temp.: 2-8°C
• SMILES string: Clc1cccc(C(=O)Nc2cnc3[nH]ccc3c2)c1Cl
• InChI: 1S/C14H9Cl2N3O/c15-11-3-1-2-10(12(11)16)14(20)19-9-6-8-4-5-17-13(8)18-7-9/h1-7H,(H,17,18)(H,19,20)
• InChI key: SIMLBFHHXAMGGM-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

AZ513 is a reversible, noncompetitive FAAH inhibitor.

AZ513 is a reversible, noncompetitive FAAH inhibitor. It also binds non-competitively at a site distinct from the catalytic site. AZ513 is 20-fold more potent against rat FAAH (IC₅₀ 27 nM) than the human form (IC₅₀ 551 nM).

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• Hazard Classifications: Acute Tox. 4 Oral
• Klasa składowania: 13 - Non Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable